#BEGIN_DRUGCARD DB02022

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
73-67-6

# ChEBI_ID:
16892

# Chemical_Formula:
C6H9N3O

# Chemical_IUPAC_Name:
(4-amino-2-methylpyrimidin-5-yl)methanol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
4-Amino-5-Hydroxymethyl-2-Methylpyrimidine

# HET_ID:
HMH

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H9N3O/c1-4-8-2-5(3-10)6(7)9-4/h2,10H,3H2,1H3,(H2,7,8,9)

# InChI_Key:
InChIKey=VUTBELPREDJDDH-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01279

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2022

# Mechanism_Of_Action:
Not Available

# Melting_Point:
198 Â°C

# Molecular_Weight_Avg:
139.1552

# Molecular_Weight_Mono:
139.074561925

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1YAK

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.26

# Predicted_LogS:
-1.1

# Predicted_Water_Solubility:
1.20e+01 g/l

# Primary_Accession_No:
DB02022

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
777

# PubChem_Substance_ID:
46508420

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01759

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=NC=C(CO)C(N)=N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:43 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M73546

# Drug_Target_1_GenBank_ID_Protein:
143729

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
tenA

# Drug_Target_1_Gene_Sequence:
>711 bp
GTGAAGTTTTCAGAAGAATGCCGCAGTGCAGCCGCAGAATGGTGGGAGGGGAGCTTTGTC
CATCCGTTCGTTCAAGGAATCGGTGACGGAACGCTTCCGATTGACCGTTTTAAATACTAC
GTACTTCAGGATTCCTATTATTTAACGCATTTTGCAAAGGTGCAGTCATTTGGTGCCGCT
TATGCGAAGGATCTTTATACAACGGGGCGGATGGCAAGCCATGCCCAAGGTACATATGAG
GCGGAAATGGCGCTTCATCGCGAGTTTGCCGAGCTGTTGGAAATCAGCGAGGAAGAGCGT
AAGGCGTTTAAGCCGTCTCCTACGGCGTACTCTTATACATCCCATATGTACCGTTCGGTT
TTGAGCGGGAATTTCGCAGAAATCTTAGCGGCCCTGCTGCCATGCTATTGGCTCTATTAC
GAGGTTGGTGAGAAATTGCTGCATTGTGATCCGGGGCATCCAATTTATCAGAAGTGGATT
GGCACATATGGCGGTGATTGGTTTAGACAACAGGTCGAGGAGCAAATCAACCGCTTTGAT
GAGCTGGCGGAAAACAGCACGGAGGAAGTGCGTGCCAAGATGAAAGAGAATTTTGTCATC
TCCAGCTACTATGAATATCAATTTTGGGGAATGGCCTATCGAAAAGAAGGCTGGTCTGAC
AGCGCCATAAAAGAGGTGGAGGAATGTGGAGCTTCACGCCATAACGGATGA

# Drug_Target_1_General_Function:
Transcription

# Drug_Target_1_General_References:
1898926	Pang AS, Nathoo S, Wong SL: Cloning and characterization of a pair of novel genes that regulate production of extracellular enzymes in Bacillus subtilis. J Bacteriol. 1991 Jan;173(1):46-54.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2815

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
27417

# Drug_Target_1_Name:
Thiaminase-2

# Drug_Target_1_Number_of_Residues:
236

# Drug_Target_1_PDB_ID:
1YAK

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF03070	TENA_THI-4

# Drug_Target_1_Protein_Sequence:
>Thiaminase-2
MKFSEECRSAAAEWWEGSFVHPFVQGIGDGTLPIDRFKYYVLQDSYYLTHFAKVQSFGAA
YAKDLYTTGRMASHAQGTYEAEMALHREFAELLEISEEERKAFKPSPTAYSYTSHMYRSV
LSGNFAEILAALLPCYWLYYEVGEKLLHCDPGHPIYQKWIGTYGGDWFRQQVEEQINRFD
ELAENSTEEVRAKMKENFVISSYYEYQFWGMAYRKEGWSDSAIKEVEECGASRHNG

# Drug_Target_1_Reaction:
thiamine + H2O = 4-amino-5-hydroxymethyl-2-methylpyrimidine + 5-(2-hydroxyethyl)-4-methylthiazole

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Stimulates the production of several extracellular degradative enzymes at the transcriptional level, probably by interfering with degS and degU, which are required for this effect. Is not an essential protein, but affects the sporulation frequency

# Drug_Target_1_SwissProt_ID:
P25052

# Drug_Target_1_SwissProt_Name:
TENA_BACSU

# Drug_Target_1_Synonyms:
EC 3.5.99.2
Thiaminase II
Transcriptional activator tenA

# Drug_Target_1_Theoretical_pI:
4.93

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
U87940

# Drug_Target_2_GenBank_ID_Protein:
1842117

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
thiD

# Drug_Target_2_Gene_Sequence:
>801 bp
ATGCAACGAATTAACGCGCTGACGATTGCCGGCACCGATCCCAGCGGCGGGGCCGGTATC
CAGGCGGATCTCAAGACCTTTTCCGCGCTGGGCGCATATGGCTGTTCGGTCATCACTGCG
CTGGTGGCCGAAAATACCTGTGGCGTACAGTCGGTGTACCGGATAGAGCCGGACTTTGTT
GCCGCTCAACTTGATTCCGTGTTCAGCGATGTGCGCATTGATACCACGAAAATCGGGATG
CTGGCGGAAACCGATATTGTCGAGGCCGTGGCGGAACGGTTACAGCGCCATCATGTACGT
AATGTGGTGCTGGATACGGTGATGCTGGCGAAAAGCGGCGATCCGCTGCTCTCGCCCTCT
GCGATAGAAACATTACGCGTCCGGCTGTTGCCGCAGGTATCGCTGATTACGCCTAATTTG
CCGGAAGCCGCAGCGTTGCTGGATGCGCCCCATGCGCGTACGGAACAGGAGATGCTGGCG
CAGGGGCGGGCGTTACTGGCGATGGGGTGTGAAGCGGTATTGATGAAAGGCGGGCATTTA
GAGGATGCGCAAAGCCCGGACTGGCTCTTTACCCGCGAGGGCGAGCAGCGTTTTAGCGCG
CCGCGTGTGAACACCAAAAATACGCATGGGACGGGCTGTACGCTGTCGGCGGCGCTGGCG
GCGTTACGGCCCCGGCATCGCAGTTGGGGAGAGACGGTAAACGAGGCGAAGGCATGGCTT
TCGGCGGCGCTGGCGCAGGCGGACACGCTGGAAGTGGGGAAGGGCATTGGTCCGGTACAT
CATTTCCACGCGTGGTGGTAG

# Drug_Target_2_General_Function:
Coenzyme transport and metabolism

# Drug_Target_2_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
9244280	Petersen LA, Downs DM: Identification and characterization of an operon in Salmonella typhimurium involved in thiamine biosynthesis. J Bacteriol. 1997 Aug;179(15):4894-900.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2652

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
28544

# Drug_Target_2_Name:
Phosphomethylpyrimidine kinase

# Drug_Target_2_Number_of_Residues:
266

# Drug_Target_2_PDB_ID:
1JXI

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF08543	Phos_pyr_kin

# Drug_Target_2_Protein_Sequence:
>Phosphomethylpyrimidine kinase
MQRINALTIAGTDPSGGAGIQADLKTFSALGAYGCSVITALVAQNTCGVQSVYRIEPDFV
AAQLDSVFSDVRIDTTKIGMLAETDIVEAVAERLQRHHVRNVVLDTVMLAKSGDPLLSPS
AIETLRVRLLPQVSLITPNLPEAAALLDAPHARTEQEMLAQGRALLAMGCEAVLMKGGHL
EDAQSPDWLFTREGEQRFSAPRVNTKNTHGTGCTLSAALAALRPRHRSWGETVNEAKAWL
SAALAQADTLEVGKGIGPVHHFHAWW

# Drug_Target_2_Reaction:
ATP + (4-amino-2-methylpyrimidin-5-yl)methyl phosphate = ADP + (4-amino-2-methylpyrimidin-5-yl)methyl diphosphate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catalyzes the phosphorylation of HMP-P to HMP-PP

# Drug_Target_2_SwissProt_ID:
P55882

# Drug_Target_2_SwissProt_Name:
THID_SALTY

# Drug_Target_2_Synonyms:
EC 2.7.4.7
HMP-P kinase
HMP-phosphate kinase

# Drug_Target_2_Theoretical_pI:
6.42

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02022
